Sarcoma  >>  crenolanib (ARO-002)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
crenolanib (ARO-002) / AROG
NCT01243346: Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

Completed
2
20
US
Crenolanib besylate (CP-868,596-26), Dose: 140mg BID
Arog Pharmaceuticals, Inc.
D842-related Mutant GIST
07/14
07/14

Download Options